APA (7th ed.) Citation

OM, B., GFR, M., NR, K., A, S., O, A., DM, D., . . . S, D. (2026). Cardio-Vasculo-Renal Benefits of SGLT2 Inhibitors in Heart Failure: A Retrospective Study from a Lower-Resource Tertiary Center. Medicina (Kaunas, Lithuania), 62(2), . https://doi.org/10.3390/medicina62020256

Chicago Style (17th ed.) Citation

OM, Bodea, et al. "Cardio-Vasculo-Renal Benefits of SGLT2 Inhibitors in Heart Failure: A Retrospective Study from a Lower-Resource Tertiary Center." Medicina (Kaunas, Lithuania) 62, no. 2 (2026). https://doi.org/10.3390/medicina62020256.

MLA (9th ed.) Citation

OM, Bodea, et al. "Cardio-Vasculo-Renal Benefits of SGLT2 Inhibitors in Heart Failure: A Retrospective Study from a Lower-Resource Tertiary Center." Medicina (Kaunas, Lithuania), vol. 62, no. 2, 2026, https://doi.org/10.3390/medicina62020256.